Day: May 16, 2023

NEW YORK, May 16, 2023 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), one of the nation’s largest providers of facility services, infrastructure solutions, and parking management, has been named to the DiversityInc list of Noteworthy companies for the first time. The DiversityInc Noteworthy Companies list is comprised of companies whose data indicates they have the potential to make the DiversityInc Top 50 list. “As home to more than 100,000 team members who serve more than 20,000 clients, ABM views diversity of backgrounds, perspectives, and experiences as a core part of our strength, both as an employer and industry leader,” said Scott Salmirs, President and CEO, ABM. “Driving diversity, equity, and inclusion (“DEI”) across every level of our organization is good for our people, our clients, our business, and our communities – and is simply...

EDISON, N.J., May 16, 2023 (GLOBE NEWSWIRE) — Zerify Inc., (OTC PINK: ZRFY), the 22-year-old cybersecurity company focused on Secure Video Conferencing & Endpoint Security is proud to announce that EZ Funding Solutions, a prominent Business Finance Advisory company purchased a license for Zerify Meet™ with Zerify Defender™ to enhance data protection measures for EZ Funding Solutions and its valued corporate and customer data. “In these times, cyber security is critical, and therefore after learning about Zerify’s services, I signed up immediately for both Zerify Meet & Zerify Defender, keeping in mind that it gives me the peace of mind knowing that I have added level of protection,” says Parag Nevatia, CEO of EZ Funding Solutions. “To know that my data is protected 24/7 and my video calls are also shielded...

Switzerland is the first European country to approve Glassia®, which received U.S. FDA approval in 2010 Glassia will be commercialized by IDEOGEN AG in Switzerland and the therapy is expected to be available to patients and providers during the second half of 2023 The current Alpha-1 Antitrypsin Deficiency (AATD) market in Switzerland is estimated to be over $15 million annuallyREHOVOT, Israel and HOBOKEN, N.J., May 16, 2023 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Swissmedic has granted marketing authorization for Glassia®[Alpha-1 Proteinase Inhibitor (Human)] in Switzerland for chronic augmentation and...

66 percent of doctors say genetic testing could lead to better outcomes because patients are more proactive about their health after learning about their DNA health profile 34 percent of doctors said they had personally taken a direct-to-consumer genetic health test SUNNYVALE, Calif., May 16, 2023 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe) today announced that a new survey, which found that primary care physicians are more and more comfortable discussing genetic testing with their patients than they were two years ago, and that more than two-thirds of those physicians who’ve taken a test themselves would recommend testing for health purposes if a patient inquired. The survey, conducted by Medscape — a leading source of clinical news, health information, and point-of-care tools for healthcare professionals — is...